Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,965.00
Bid: 1,968.00
Ask: 1,970.00
Change: 7.00 (0.36%)
Spread: 2.00 (0.102%)
Open: 1,977.00
High: 1,980.00
Low: 1,957.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Glencore leads fallers early on

Wed, 29th Aug 2012 08:25

- Spain a concern as Catalonia needs aid- Markets await Bernanke- Ex-div Glencore a heavy faller early onEx-div stocks and miners were weighing heavily on the FTSE 100 index in early trading on Wednesday morning with worries about Spain weighing on sentiment.It was revealed yesterday that the recession in Spain was deeper than first thought in the second quarter, with concerns intensifying after reports that the regional government of Catalonia would be requesting around €5bn from Spain's liquidity fund."Catalonia also seems stubborn on political conditions relating to the emergency funds, causing some anxiety for potential future lenders to Spain as a whole. This is pretty big news for the Eurozone as any seemed resistance to conditions relating to any emergency funds could cause a pretty big headache down the line," said trader Simon Furlong from Spreadex.Economists at FxPro said in an e-mailed note this morning that investors are now waiting for Ben Bernanke for a lift: "As the Chairman of the US Federal Reserve gets up to speak on Friday, his words will determine whether markets are imbued with hope or despair ahead of the next US monetary policy meeting in September."FTSE 100: Ex-div stocks, miners down early onEx-dividend stocks were providing a drag this morning, including heavyweights Croda International, Glencore, Legal & General and Xstrata.Nevertheless, Glencore and Xstrata were being pressured lower by reports that Xstrata shareholder Norges Bank Investment Management has raised its stake in the miner in the last few weeks. The Norwegian fund is expected to join forces with Qatari Holdings to vote to block the merger between the two groups.Copper producer Antofagasta was also lower despite beating EPS estimates in the first half as a decrease in copper prices was offset by higher levels of production.Outsourcing group Serco was higher after saying that it expects good growth in full-year organic revenues in 2012 despite a 2.1% fall in the first half.FTSE 250: RusPetro drops after swinging into the redWest Siberia-focused oil and gas firm RusPetro was a heavy faller in the opening hour after reporting a pre-tax loss of $26.4m, compared with a profit of $0.6m in the first half of last year. Revenues, however, tripled as production ramps up.UK and Continental property investment firm Hansteen gained after reporting a sharp rise in half-year profit despite adverse currency movement. On a like-for-like basis, occupancy, values and rent all improved.A host of second-tier stocks went ex-dividend today and were trading in the red, such as African Barrick Gold, Devro, Ferrexpo, Henderson, Hikma, Hochschild Mining, Lancashire Holdings, Rotork, Wood Group, Micro Focus, Rank Group and Stagecoach.FTSE 100 - RisersSSE (SSE) 1,373.00p +1.18%Serco Group (SRP) 567.00p +0.80%Hargreaves Lansdown (HL.) 616.00p +0.65%Centrica (CNA) 328.90p +0.40%Reed Elsevier (REL) 580.00p +0.35%Pennon Group (PNN) 740.50p +0.27%WPP (WPP) 838.00p +0.18%Hammerson (HMSO) 451.60p +0.18%Admiral Group (ADM) 1,179.00p +0.17%Standard Chartered (STAN) 1,419.00p +0.11%FTSE 100 - FallersGlencore International (GLEN) 368.50p -4.04%Eurasian Natural Resources Corp. (ENRC) 310.70p -2.48%Rio Tinto (RIO) 2,793.00p -2.41%Xstrata (XTA) 918.00p -2.26%Legal & General Group (LGEN) 128.00p -1.99%Aviva (AV.) 321.00p -1.86%International Consolidated Airlines Group SA (CDI) (IAG) 142.40p -1.73%Anglo American (AAL) 1,834.50p -1.66%Vedanta Resources (VED) 889.00p -1.66%BHP Billiton (BLT) 1,905.50p -1.40%FTSE 250 - RisersSt James's Place (STJ) 346.99p +3.21%SVG Capital (SVI) 279.90p +3.13%Chemring Group (CHG) 332.60p +2.65%Homeserve (HSV) 216.50p +1.88%Kier Group (KIE) 1,320.00p +1.85%Galliford Try (GFRD) 632.00p +1.69%Perform Group (PER) 380.00p +1.55%Brewin Dolphin Holdings (BRW) 146.80p +1.52%Spirent Communications (SPT) 156.70p +1.42%ITE Group (ITE) 203.10p +1.30%FTSE 250 - FallersRuspetro (RPO) 130.60p -7.70%Redrow (RDW) 137.80p -4.90%Kentz Corporation Ltd. (KENZ) 369.40p -3.02%Dunelm Group (DNLM) 587.50p -2.81%Micro Focus International (MCRO) 544.50p -2.77%Henderson Group (HGG) 104.80p -2.69%Ted Baker (TED) 991.50p -2.51%Rank Group (RNK) 137.03p -2.47%New World Resources A Shares (NWR) 288.80p -2.43%Centamin (DI) (CEY) 77.30p -2.28%BC
More News
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.